(571) 259-9384
Seniorllc@gmail.com

13800 Coppermine Rd,
Herndon, Va 20171

**Medicaid certified**
Available 24/7

Follow Us

Blog Masonry

Senior Home Care Services  >  Blog Masonry

Loneliness and Social Isolation Linked to Serious Health Conditions

Please call Senior Home care Services LLC. @ 571-259-9384 to speak to our trained specialist on caregivers for your well being and safety at home. Social isolation was associated with abouta 50% increased risk of dementia and otherserious medical conditions. Loneliness and social isolation in older adults...

Study claims Ozempic & Wegovy may reduce risk of dementia.  Call 571-259-9384 to discuss how Senior Home care services can provide care for your loved ones at home and keep them safe, and if you cant afford the care we can discuss how you can get care for FREE.

    Previous studies showed that the medications known as GLP-1 agonists made by Danish pharma giant Novo Nordisk improved the cognitive behaviour and pathological features in Alzheimer's disease patients and animals. This may be related to the improvement of glucose metabolism in the brain. However, their mechanisms have not...

10 Early Signs and Symptoms of Alzheimer’s and Dementia

10 Early Signs and Symptoms of Alzheimer's and Dementia Senior Home Care Services has Trained caregivers that can help please call 571-259-9384 Memory loss that disrupts daily life may be a symptom of Alzheimer's or other dementia. Alzheimer's is a brain disease that causes a slow decline in memory,...

Fall Risk Assessment

Senior Homecare Services LLC. 571-259-9384 What is a fall risk assessment? Falls are common in adults 65 years of age and older. In the United States, about a third of older adults who live at home and about half of people living in nursing homes fall at least...

Newest drug for Alzheimer’s

Senior Homecare Services can provide care for patients with Alzheimer's Just call 571-259-9384 By Berkeley Lovelace Jr. The Food and Drug Administration on Friday approved an Alzheimer’s drug shown in clinical trials to slow cognitive decline in patients in the early stages of the illness. The approval offers patients renewed hope...